UZEDY
PeakNDASUBCUTANEOUSSUSPENSION, EXTENDED RELEASE
Approved
Apr 2023
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 5h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
UZEDY is a subcutaneous, extended-release suspension formulation of risperidone, an atypical antipsychotic approved by the FDA in April 2023. It is indicated for the treatment of schizophrenia, bipolar disorder, and irritability associated with autism spectrum disorder. The drug works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, reducing psychotic symptoms and mood disturbance.
$0.01BPart D
Peak15.4 years to LOEEarly-stage peak product with modest current spending ($10M in 2023) but strong patent protection through 2042 suggests long-term revenue potential and stable commercial team investment.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on UZEDY offers career exposure to a newly approved, long-acting psychiatric product in a stable but competitive market. The strong patent portfolio and peak-stage lifecycle provide medium-term job security and opportunities in payer negotiations, specialty pharmacy management, and prescriber education.
Brand ManagerMarket Access Manager
Worked on UZEDY at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.